Pfizer has already made “several hundred thousand doses” of a potential coronavirus vaccine as it prepares to seek emergency use in the US by November.

The drugmaker told the Mail on Sunday that scientists in its main British lab have also unearthed drugs that could provide a potential complete cure for COVID-19, as opposed to merely a preventative vaccine.

The firm’s UK boss, Ben Osborn, said the company is manufacturing the huge stockpile of its current vaccine candidate in Belgium “at risk and at scale,” calling it “tremendously exciting.”

Last year, Dr. Sergio Canavero created quite the ruckus (to put it mildly) when he vowed to be the primary person to transplant a person’s head onto a deceased donor’s body. Yes, he’s planning on attempting the world’s first caput transplant (or body transplant, betting on how you study it).

In fact, it’s been a few years since his initial proclamation, and therefore the Italian neurosurgeon still stands firm on his declaration, despite claims from other experts that it’s nothing but a PR Stunt (at best) or a hoax. Some have even hypothesized it’s all just a plot meant to push Metal Gear Solid.

“People are doing heroic work, but they are really getting to the point where it’s going to be literally unsustainable,” an infectious diseases doctor says.

Texas, Puerto Rico and the U.S. Virgin Islands stand alone in having recorded decreases in numbers of Covid-19 cases over the last two weeks as the country braces for a possible “third peak” of the disease.

Although Texas reported a “slight decrease” in cases over the 14-day period that ended Saturday, its news was better than elsewhere: 38 states, Washington, D.C., and Guam all recorded increases in cases over the last 14 days, and nine states have plateaued, according to NBC News tallies. Rhode Island, which, like Texas, has also had a net decrease, does not report data over the weekend, and Missouri is not reporting data because of a technology issue.

Cases numbers have spiked in Vermont and New Mexico as they battle spikes of about 117 percent in case numbers over the last two weeks.

Blocking Immune System Pathway May Stop COVID-19 Infection, Prevent Severe Organ Damage

While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing on better understanding how SARS-CoV-2 attacks the body in the search for other means of stopping its devastating impact. The key to one possibility — blocking a protein that enables the virus to turn the immune system against healthy cells — has been identified in a recent study by a team of Johns Hopkins Medicine researchers.

Based on their findings, the researchers believe that inhibiting the protein, known as factor D, also will curtail the potentially deadly inflammatory reactions that many patients have to the virus.